934 results on '"Ishii, Ken J"'
Search Results
2. Bisphenol A triggers activation of ocular immune system and aggravates allergic airway inflammation
3. Prime-boost-type PspA3 + 2 mucosal vaccine protects cynomolgus macaques from intratracheal challenge with pneumococci
4. A stress sensor, IRE1α, is required for bacterial-exotoxin-induced interleukin-1β production in tissue-resident macrophages
5. Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism
6. Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community’s view
7. TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells
8. Alveolar macrophages instruct CD8+ T cell expansion by antigen cross-presentation in lung
9. Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen
10. Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein
11. In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy
12. CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
13. Tridecylcyclohexane in incomplete Freund's adjuvant is a critical component in inducing experimental autoimmune diseases.
14. MyD88 in osteoclast and osteoblast lineages differentially controls bone remodeling in homeostasis and malaria.
15. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation
16. Acute malaria suppresses the B lymphocytic niche in the bone marrow through the alteration of CXCL12-abundant reticular cells
17. Integrin α5 regulates motility of human monocyte‐derived Langerhans cells during immune response
18. Making innate sense of mRNA vaccine adjuvanticity
19. Strategic Outlook toward 2030: Japan's research for allergy and immunology – Secondary publication
20. Virological characteristics of the SARS-CoV-2 JN.1 variant
21. Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine
22. TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model
23. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a Partial STING Agonist, Competes for Human STING Activation
24. Immune tolerance caused by repeated P. falciparum infection against SE36 malaria vaccine candidate antigen and the resulting limited polymorphism
25. RAE1 Ligands for the NKG2D Receptor Are Regulated by STING-Dependent DNA Sensor Pathways in Lymphoma
26. Near-infrared photoimmunotherapy as a complementary modality to in situ vaccine in a preclinical pancreatic cancer model
27. Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial
28. Challenges in developing personalized neoantigen cancer vaccines
29. Identification of a Self-Assembling Small-Molecule Cancer Vaccine Adjuvant with an Improved Toxicity Profile
30. Secretion of mitochondrial DNA via exosomes promotes inflammation in Behçet's syndrome
31. Corrigendum: Dendritic cell proliferation by primary cilium in atopic dermatitis
32. Particulate-Driven Type-2 Immunity and Allergic Responses
33. Development of screening method for intranasal influenza vaccine and adjuvant safety in preclinical study
34. Combination and inducible adjuvants targeting nucleic acid sensors
35. BLT1 mediates commensal bacteria-dependent innate immune signals to enhance antigen-specific intestinal IgA responses
36. Pulmonary phagocyte-derived NPY controls the pathology of severe influenza virus infection
37. Evaluation of marker gene expression as a potential predictive marker of leukopenic toxicity for inactivated influenza vaccines
38. A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP
39. Intratumoural Delivery of mRNA Loaded on a Cationic Hyper-Branched Cyclodextrin-Based Polymer Induced an Anti-Tumour Immunological Response in Melanoma
40. Nano-particulate Toll-like Receptor 9 Agonist Potentiates the Antitumor Activity of Anti-Glypican-1 Antibody
41. A combination of TLR9 and STING agonists induces potent neopeptide-specific T cell immunity and improves ICB efficacy in tumor models
42. Novel Adjuvants
43. A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests
44. Antibody Response Following the Intranasal Administration of SARS-CoV-2 Spike Protein-CpG Oligonucleotide Vaccine.
45. Akkermansia muciniphila induces slow extramedullary hematopoiesis via cooperative IL‐1R/TLR signals.
46. Activation of Target-Tissue Immune-Recognition Molecules by Double-Stranded Polynucleotides
47. Lymphoid tissue-resident Alcaligenes LPS induces IgA production without excessive inflammatory responses via weak TLR4 agonist activity
48. Tissue-specific immunopathology during malaria infection
49. Dendritic cell proliferation by primary cilium in atopic dermatitis
50. Roles of TRPM4 in immune responses in keratinocytes and identification of a novel TRPM4-activating agent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.